Life Sciences

  • Microbiome / Nutrition / Foodtech / Lifestyle
  • Medtech / Connected health / Digital health
  • Biotech & pharmaceuticals
  • Industrial Biotech & Cleantech
  • Animal health / Animal Feed & Nutrition

Read more

Digital Technologies

  • Fintech
  • Retailtech
  • Other digital innovative solutions
  • Hardware & telecom

Read more

Sport & Performance Capital

  • Sport-Health
  • Equipment
  • Food-Nutrition
  • IOT-Digital
  • Sports practice

Read more

Blue Economy

  • Sustainable aquaculture
  • Nutrition Cosmetics Health
  • Industrial Products & Biomaterials
  • Biopolymers and biopackaging
  • Digitalization Blue 3.0
  • Recycling, Bioremediation
  • Climate & Carbon
  • Bioenergies, hydrogen

Read more

News

  • MaaT Pharma Presents Pivotal ARES Phase 3 Results for MaaT013 (Xervyteg®) in Acute GvHD at ASH 2025 Annual Congress and Announces 54% 1-Year Overall Survival
    8 December 2025

    MaaT Pharma Presents Pivotal ARES Phase 3 Results for MaaT013 (Xervyteg®) in Acute GvHD at ASH 2025 Annual Congress and Announces 54% 1-Year Overall Survival

    MaaT Pharma (EURONEXT: MAAT – the “Company”), a...

  • First patient dosed in Citryll’s phase IIA Hidradenitis Suppurativa Trial
    8 December 2025

    First patient dosed in Citryll’s phase IIA Hidradenitis Suppurativa Trial

    Citryll, a biotech company pioneering a transformative...

  • Enterome OncoMimics™ immunotherapy EO2401 shows survival benefit in Phase 2 glioblastoma trial
    2 December 2025

    Enterome OncoMimics™ immunotherapy EO2401 shows survival benefit in Phase 2 glioblastoma trial

    Enterome, a clinical-stage company pioneering...

  • MaaT Pharma announces the successful completion of its Global Offering of €9.1 million
    14 November 2025

    MaaT Pharma announces the successful completion of its Global Offering of €9.1 million

    MaaT Pharma (EURONEXT: MAAT – the “Company”), a...

  • Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M (US $ 401M)
    30 October 2025

    Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M (US $ 401M)

    • New investors Fidelity Management & Research...

    Read more...